016580 — Whanin Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Annual cashflow statement for Whanin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	23,191	26,459	23,734	29,774	23,381
Depreciation
Amortisation
Non-Cash Items	6,986	7,713	7,443	4,480	7,268
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-10,999	-2,578	-18,700	-17,244	-17,937
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	22,755	35,318	16,851	23,197	20,693
Capital Expenditures	-8,224	-4,762	-67,759	-31,489	-29,381
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	8,827	2,640	28,817	22,057	11,286
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	603	-2,122	-38,942	-9,432	-18,095
Financing Cash Flow Items	—	—	—	-171	-4.95
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5,187	-5,194	-5,130	-5,166	-5,051
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	18,092	27,982	-27,280	8,591	-2,219